These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7850405)

  • 1. The sodium pump in hypertension.
    Graves SW
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):107-11. PubMed ID: 7850405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular effects of altered sodium, potassium pump activity.
    Mulvany MJ
    Scand J Clin Lab Invest Suppl; 1986; 180():40-8. PubMed ID: 3012761
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of sodium pump inhibitor induced vascular smooth muscle contraction with digibind. Stoichiometry and its implications.
    Krep HH; Graves SW; Price DA; Lazarus M; Ensign A; Soszynski PA; Hollenberg NK
    Am J Hypertens; 1996 Jan; 9(1):39-46. PubMed ID: 8834705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial stimulation of sodium pump in cultured vascular smooth muscle.
    Redondo J; Peiró C; Rodríguez-Mañas L; Salaices M; Marín J; Sánchez-Ferrer CF
    Hypertension; 1995 Jul; 26(1):177-85. PubMed ID: 7607721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of endogenous inhibition of Na-K-ATPase in human hypertension--sodium pump activity as a determinant of peripheral vascular resistance.
    Kramer HJ; Glänzer K; Sorger M
    Clin Exp Hypertens A; 1985; 7(5-6):769-82. PubMed ID: 2990771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the Na+, K+-ATPase in the regulation of vascular smooth-muscle contractility, and its relationship to essential hypertension.
    Aronson JK
    Biochem Soc Trans; 1984 Dec; 12(6):943-5. PubMed ID: 6099292
    [No Abstract]   [Full Text] [Related]  

  • 7. Endogenous sodium pump inhibition: current status and therapeutic opportunities.
    Hollenberg NK; Graves SW
    Prog Drug Res; 1996; 46():9-42. PubMed ID: 8754202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial modulation of ouabain-induced contraction and sodium pump activity in aortas of normotensive Wistar-Kyoto and spontaneously hypertensive rats.
    Ponte A; Marín J; Arribas S; González R; Barrús MT; Salaices M; Sánchez-Ferrer CF
    J Vasc Res; 1996; 33(2):164-74. PubMed ID: 8630350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a circulating Na,K-pump inhibitor in essential hypertension.
    Hilton PJ
    Scand J Clin Lab Invest Suppl; 1986; 180():65-71. PubMed ID: 3012764
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of a humoral sodium-potassium pump inhibitor in experimental low renin hypertension.
    Haddy FJ; Pamnani M; Clough D; Huot S
    Life Sci; 1982 Feb 15-22; 30(7-8):571-5. PubMed ID: 6280009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological role of cation transport and natriuretic factors in hypertension.
    Haddy FJ; Pamnani MB; Clough DL
    Hypertension; 1987 Nov; 10(5 Pt 2):I101-7. PubMed ID: 2824358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC proteins.
    Blaustein MP; Hamlyn JM
    Biochim Biophys Acta; 2010 Dec; 1802(12):1219-29. PubMed ID: 20211726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium stimulates the vascular smooth muscle cell Na/K pump of normotensive and hypertensive rats by a protein kinase C pathway.
    Redondo J; Rodríguez-Martínez MA; Alonso MJ; Salaices M; Balfagón G; Marín J
    J Hypertens; 1996 Nov; 14(11):1301-7. PubMed ID: 8934358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium, Na+-K+ pump inhibitor and low-renin hypertension.
    Haddy FJ
    Clin Invest Med; 1987 Nov; 10(6):547-54. PubMed ID: 2831002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral endothelial mechanisms in increased permeability in chronic hypertension.
    Nag S
    Adv Exp Med Biol; 1993; 331():263-6. PubMed ID: 8392781
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electrical responses of aortic endothelium in spontaneously hypertensive rats].
    Bondarenko OI; Sahach VF
    Fiziol Zh (1994); 2002; 48(4):75-9. PubMed ID: 12226931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic overexpression of translationally controlled tumor protein induces systemic hypertension via repression of Na+,K+-ATPase.
    Kim MJ; Kwon JS; Suh SH; Suh JK; Jung J; Lee SN; Kim YH; Cho MC; Oh GT; Lee K
    J Mol Cell Cardiol; 2008 Jan; 44(1):151-9. PubMed ID: 17976639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of a humoral Na+,K+-ATPase inhibitor in regulating precapillary vessel tone.
    Haddy FJ
    J Cardiovasc Pharmacol; 1984; 6 Suppl 2():S439-56. PubMed ID: 6206353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous inhibitors of the Na,K pump.
    Doris PA
    Miner Electrolyte Metab; 1996; 22(5-6):303-10. PubMed ID: 8933501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure in essential hypertension correlates with the concentration of a circulating inhibitor of the sodium pump.
    Moreth K; Kuske R; Renner D; Schoner W
    Klin Wochenschr; 1986 Mar; 64(5):239-44. PubMed ID: 3009961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.